CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,229 | +22.2% | 8,340,193 | -0.2% | 10.94% | +22.8% |
| Q2 2023 | $186,021 | +2.6% | 8,360,485 | -0.1% | 8.91% | -4.4% |
| Q1 2023 | $181,295 | +30.8% | 8,370,017 | +22.6% | 9.31% | +23.5% |
| Q4 2022 | $138,621 | -99.9% | 6,825,262 | -1.8% | 7.54% | -24.2% |
| Q3 2022 | $178,226,000 | +7.2% | 6,951,077 | -0.6% | 9.95% | +14.5% |
| Q2 2022 | $166,276,000 | +6.8% | 6,992,248 | +1.2% | 8.69% | +25.0% |
| Q1 2022 | $155,644,000 | +16.7% | 6,911,376 | +2.6% | 6.95% | +15.5% |
| Q4 2021 | $133,410,000 | -3.9% | 6,737,898 | -4.5% | 6.02% | -5.4% |
| Q3 2021 | $138,810,000 | -10.8% | 7,053,370 | -0.3% | 6.36% | -8.0% |
| Q2 2021 | $155,565,000 | -5.9% | 7,071,155 | +1.8% | 6.91% | -10.5% |
| Q1 2021 | $165,263,000 | -13.5% | 6,946,732 | -4.9% | 7.72% | -18.2% |
| Q4 2020 | $191,029,000 | +46.5% | 7,302,318 | -2.5% | 9.43% | +5.4% |
| Q3 2020 | $130,394,000 | +2.0% | 7,491,753 | -1.4% | 8.95% | +21.9% |
| Q2 2020 | $127,820,000 | +34.3% | 7,599,289 | -5.1% | 7.34% | +14.5% |
| Q1 2020 | $95,164,000 | -1.9% | 8,003,723 | -0.1% | 6.41% | +22.2% |
| Q4 2019 | $96,974,000 | -21.3% | 8,014,351 | -8.0% | 5.25% | -12.6% |
| Q3 2019 | $123,147,000 | +29.6% | 8,712,176 | +2.2% | 6.01% | +31.5% |
| Q2 2019 | $95,018,000 | -3.3% | 8,521,799 | +1.8% | 4.57% | -2.4% |
| Q1 2019 | $98,287,000 | -12.4% | 8,372,001 | -0.3% | 4.68% | -20.9% |
| Q4 2018 | $112,142,000 | -5.0% | 8,393,889 | -0.3% | 5.92% | +19.0% |
| Q3 2018 | $118,024,000 | +2.6% | 8,418,260 | +15.1% | 4.97% | -6.8% |
| Q2 2018 | $115,023,000 | +2.6% | 7,316,990 | +7.3% | 5.34% | -2.4% |
| Q1 2018 | $112,149,000 | -10.3% | 6,817,540 | -1.5% | 5.47% | -4.9% |
| Q4 2017 | $125,042,000 | -5.8% | 6,923,695 | +0.6% | 5.75% | -16.8% |
| Q3 2017 | $132,767,000 | +53.9% | 6,879,098 | -5.9% | 6.92% | +47.6% |
| Q2 2017 | $86,289,000 | +0.4% | 7,312,635 | -6.8% | 4.68% | +2.2% |
| Q1 2017 | $85,957,000 | +45.1% | 7,842,835 | -3.9% | 4.58% | +42.1% |
| Q4 2016 | $59,239,000 | +5.9% | 8,159,679 | -5.2% | 3.23% | +3.4% |
| Q3 2016 | $55,961,000 | +11.8% | 8,609,429 | -6.1% | 3.12% | +5.7% |
| Q2 2016 | $50,059,000 | – | 9,168,240 | – | 2.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |